Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M14,552Revenue (TTM) $M924Net Margin (%)-20.5Altman Z-Score6.2
Enterprise Value $M14,763EPS (TTM) $-1.2Operating Margin %-13.6Piotroski F-Score2
P/E(ttm)--Beneish M-Score-2.3Pre-tax Margin (%)-18.3Higher ROA y-yY
Price/Book6.410-y EBITDA Growth Rate %--Quick Ratio1.8Cash flow > EarningsN
Price/Sales15.65-y EBITDA Growth Rate %--Current Ratio2.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-5.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-8.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M162ROIC % (ttm)-6.3Gross Margin Increase y-yN

Gurus Latest Trades with BMRN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BMRNJoel Greenblatt 2015-06-30 Sold Out $112.05 - $140
($123.93)
$ 89.65-28%Sold Out0
BMRNJoel Greenblatt 2015-03-31 Buy $90.28 - $129.14
($105.95)
$ 89.65-15%New holding4,195
BMRNJoel Greenblatt 2014-12-31 Sold Out $67.27 - $94.19
($83.42)
$ 89.657%Sold Out0
BMRNJoel Greenblatt 2014-09-30 Buy $55.78 - $73
($65.82)
$ 89.6536%New holding3,885
BMRNMeridian Funds 2013-06-30 Sold Out -0.09%$54.72 - $70.3
($62.32)
$ 89.6544%Sold Out0
BMRNMeridian Funds 2013-03-31 Reduce-0.17%$49.2 - $62.39
($56.51)
$ 89.6559%Reduce -69.03%40,700
BMRNMeridian Funds 2012-12-31 Reduce-0.3%$36.78 - $50.17
($45.59)
$ 89.6597%Reduce -60.99%131,400
BMRNGeorge Soros 2012-06-30 Sold Out -0.15%$32.53 - $38.87
($36.01)
$ 89.65149%Sold Out0
BMRNGeorge Soros 2012-03-31 Add0.11%$33.68 - $38.34
($32.99)
$ 89.65172%Add 300.00%300,000
BMRNGeorge Soros 2011-12-31 Reduce-0.05%$30.07 - $35.38
($32.81)
$ 89.65173%Reduce -57.14%75,000
BMRNGeorge Soros 2011-06-30 Add0.07%$24.93 - $28.455
($26.32)
$ 89.65241%Add 862.36%191,510
BMRNMeridian Funds 2011-03-31 Reduce-0.28%$23.46 - $28.29
($25.46)
$ 89.65252%Reduce -51.54%348,800
BMRNGeorge Soros 2011-03-31 Buy 0.01%$23.46 - $28.29
($25.46)
$ 89.65252%New holding19,900
BMRNGeorge Soros 2010-09-30 Sold Out -0.02%$18.24 - $23.09
($20.93)
$ 89.65328%Sold Out0
BMRNMeridian Funds 2010-03-31 Add0.13%$18.75 - $23.81
($20.92)
$ 89.65329%Add 20.83%795,900
BMRNGeorge Soros 2010-03-31 Add$18.75 - $23.81
($20.92)
$ 89.65329%Add 35.87%30,300
BMRNGeorge Soros 2009-12-31 Buy 0.01%$15.49 - $18.98
($17.17)
$ 89.65422%New holding22,300
BMRNMeridian Funds 2009-09-30 Buy 0.53%$13.86 - $18.33
($15.84)
$ 89.65466%New holding658,700
BMRNBill Gates 2009-06-30 Sold Out -0.02%$11.92 - $15.94
($13.79)
$ 89.65550%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BMRN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BMRN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
FUCHS HENRY JEVP, Chief Medical Officer 2016-05-26Sell15,000$87.812.1view
SPIEGELMAN DANIEL KEVP, CFO 2016-05-23Sell3,769$87.072.96view
BAFFI ROBERTEVP, Technical Operations 2016-05-18Sell5,000$87.052.99view
Davis George EricEVP, General Counsel 2016-05-10Sell14,658$85.115.33view
BIENAIME JEAN JACQUESCEO 2016-05-05Sell50,000$80.1511.85view
Ajer Jeffrey RobertEVP, Chief Commercial Officer 2016-05-03Sell415$86.034.21view
BIENAIME JEAN JACQUESCEO 2016-05-02Sell36,500$85.015.46view
Davis George EricEVP, General Counsel 2016-03-14Sell1,996$86.213.99view
Ajer Jeffrey RobertSVP, Chief Commercial Officer 2016-03-04Sell1,255$88.421.39view
SPIEGELMAN DANIEL KEVP, CFO 2016-03-02Sell4,623$86.124.1view

Press Releases about BMRN :

Quarterly/Annual Reports about BMRN:

News about BMRN:

Articles On GuruFocus.com
Spiros Segalas Buys McDonald's, Microsoft, Alibaba May 05 2016 
Kyle Bass Sells Stakes in 11 Health Care Companies Mar 01 2016 
J.P. Morgan’s 3 Biotechnology Picks Apr 14 2015 
You Can No Longer Ignore Biotech Feb 07 2014 
Weekly Top Insider Sells: AAPL, GILD, BMRN, and PCLN Nov 19 2012 
WEEKLY CFO SELLS HIGHLIGHT: VVUS, DIS, SNPS, TXRH, BMRN Mar 04 2012 
5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 
Weekly CFO Sells Highlight: MSCC, BMRN, VAL, CUTR, REX, CIEN Oct 02 2011 
BioMarin Pharmaceutical Inc. Reports Operating Results (10-K) Feb 24 2011 
BioMarin Pharmaceutical Inc. (BMRN) CEO Jean Jacques Bienaime sells 1,000 Shares Dec 13 2010 

More From Other Websites
BioMarin to Stop Developing its Duchenne Muscle Disease Drug May 31 2016
BioMarin Announces Withdrawal of Market Authorization Application for Kyndrisa™ (drisapersen) in... May 31 2016
4:05 pm BioMarin withdraws market authorization application for Kyndrisa (drisapersen) in Europe May 31 2016
Sarepta: What the Bulls Say May 26 2016
Sarepta: We've Seen This Before May 26 2016
Sarepta Investors Get Carried Away May 25 2016
Sarepta Therapeutics: Not So Fast May 25 2016
Incyte Guidance on Jakafi Sends Stock High May 24 2016
A Scarcity of Biotech Assets for Buyouts? May 20 2016
XBI Large-Caps: Why Is BioMarin Inching Higher? May 19 2016
ETF’s with exposure to BioMarin Pharmaceutical, Inc. : May 19, 2016 May 18 2016
US open: Wall Street lower after slightly mixed data May 17 2016
BioMarin Pharmaceutical, Inc. breached its 50 day moving average in a Bullish Manner : BMRN-US : May... May 17 2016
Mariner Investment’s Top Healthcare Picks May 16 2016
AbSci Appoints Daniel Gold, Ph.D. to Board of Directors May 16 2016
​Wave to begin trials next year on 'more efficient' drug for Duchenne May 09 2016
4 Major FDA Decisions Expected by June May 08 2016
BIOMARIN PHARMACEUTICAL INC Financials May 06 2016
3 Biotech Stocks Buoyed By Potential Blockbuster Drugs May 06 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)